Enhanced bovine herpesvirus type 1 neutralization by multimerized single-chain variable antibody fragments regardless of differential glycosylation

Clinical and Vaccine Immunology

Volumn 19, Issue 8, 2012, Pages 1150-1157

  Pasman, Yfke ^a   Nagy, Eva ^a   Kaushik, Azad K ^a  

^a UNIVERSITY OF GUELPH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; VIRUS ENVELOPE PROTEIN;

ANIMAL CELL; ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; BOVINE HERPES VIRUS; CONTROLLED STUDY; GLYCOSYLATION; IN VITRO STUDY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS NEUTRALIZATION; WESTERN BLOTTING;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; BASE SEQUENCE; BLOTTING, WESTERN; EPITOPES; GENE EXPRESSION; GLYCOSYLATION; HERPESVIRUS 1, BOVINE; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; NEUTRALIZATION TESTS; PICHIA; PROTEIN MULTIMERIZATION; RECOMBINANT PROTEINS; SINGLE-CHAIN ANTIBODIES;

EID: 84864540907     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00130-12     Document Type: Article

References (25)

1. Arndt KM, Muller KM, Pluckthun A. 1998. Factors influencing the dimer to monomer transition of an antibody single-chain Fv fragment. Biochemistry 37:12918-12926. (Pubitemid 28433525)
2. Atwell JL, et al. 1999. scFv multimers of the anti-neuraminidase antibody NC10: length of the linker between VH and VL domains dictates precisely the transition between diabodies and triabodies. Protein Eng. 12:597-604. (Pubitemid 29368967)
3. Brumeanu TD, et al. 1996. Engineering of doubly antigenized immunoglobulins expressing T and B viral epitopes. Immunotechnology 2:85-95.
4. Daly R, Hearn MT. 2005. Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J. Mol. Recognit. 18:119-138. (Pubitemid 40328574)
5. Desplancq D, King DJ, Lawson AD, Mountain A. 1994. Multimerization behaviour of single chain Fv variants for the tumour-binding antibody B72.3. Protein Eng. 7:1027-1033. (Pubitemid 24256883)
6. Dolezal O, et al. 2000. ScFv multimers of the anti-neuraminidase antibody NC10: shortening of the linker in single-chain Fv fragment assembled in V(L) to V(H) orientation drives the formation of dimers, trimers, tetramers and higher molecular mass multimers. Protein Eng. 13:565-574.
7. Fang M, Dai X, Theilmann DA. 2007. Autographa californica multiple nucleopolyhedrovirus EXON0 (ORF141) is required for efficient egress of nucleocapsids from the nucleus. J. Virol. 81:9859-9869. (Pubitemid 350067689)
8. Filpula D. 2007. Antibody engineering and modification technologies. Biomol. Eng. 24:201-215. (Pubitemid 46755015)
9. Gala FA, Morrison SL. 2004. V region carbohydrate and antibody expression. J. Immunol. 172:5489-5494. (Pubitemid 38542049)
10. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. 1989. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 77:61-68. (Pubitemid 19125654)
11. Jones C, Chowdhury S. 2007. A review of the biology of bovine herpesvirus type 1 (BHV-1), its role as a cofactor in the bovine respiratory disease complex and development of improved vaccines. Anim. Health Res. Rev. 8:187-205.
12. Kaas Q, Ehrenmann F, Lefranc MP. 2007. IG, TR and IgSF, MHC and MhcSF: what do we learn from the IMGT Colliers de Perles? Brief. Funct. Genomic Proteomic 6:253-264. (Pubitemid 351894484)
13. Kohler G, Milstein C. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
14. Kortt AA, Dolezal O, Power BE, Hudson PJ. 2001. Dimeric and trimeric antibodies: high avidity scFvs for cancer targeting. Biomol. Eng. 18:95-108. (Pubitemid 32889609)
15. Koti M, Farrugia W, Nagy E, Ramsland PA, Kaushik AK. 2010. Construction of single-chain Fv with two possible CDR3H conformations but similar inter-molecular forces that neutralize bovine herpesvirus 1. Mol. Immunol. 47:953-960.
16. Koti M, Nagy E, Kaushik AK. 2011. A single point mutation in framework region 3 of heavy chain affects viral neutralization dynamics of single-chain Fv against bovine herpes virus type 1. Vaccine 29:7905-7912.
17. .Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
18. Lefranc MP, et al. 2005. IMGT, the international ImMunoGeneTics information system. Nucleic Acids Res. 33:D593-D597. doi:33/suppl-1/ D593 [pii]10.1093/nar/gki065.
19. Levings RL, Stoll IR. February 1992. Bovine monoclonal antibodies to bovine herpesvirus I from sequential fusion heterohybrodimas. US patent 5,087,693.
20. Macauley-Patrick S, Fazenda ML, McNeil B, Harvey LM. 2005. Heterologous protein production using the Pichia pastoris expression system. Yeast 22:249-270. (Pubitemid 40528349)
21. Nandi S, Kumar M, Manohar M, Chauhan RS. 2009. Bovine herpes virus infections in cattle. Anim. Health Res. Rev. 10:85-98.
22. Schwyzer M, Ackermann M. 1996. Molecular virology of ruminant herpesviruses. Vet. Microbiol. 53:17-29. (Pubitemid 27013941)
23. Tanfous NGB, Kallel H, Jarboui MA, Fathallah DM. 2006. Expression in Pichia pastoris of a recombinant scFv form of MAb 107, an anti human CD11b integrin antibody. Enzyme Microb. Technol. 38:636-642. (Pubitemid 43111635)
24. van Drunen Littel-van den Hurk S. 2006. Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. Vet. Microbiol. 113:275-282.
25. Yates WD. 1982. A review of infectious bovine rhinotracheitis, shipping fever pneumonia and viral-bacterial synergism in respiratory disease of cattle. Can. J. Comp. Med. 46:225-263. (Pubitemid 12027866)